Comparison Between Dentine Autograft VS Platelet Rich Fibrin in Extraction Socket Bone Healing
August 27, 2026 updated by: Eman abdelbaki, Cairo University
Histomorphological Evaluation of Alveolar Bone Healing Using Dentin Autograft Mixed With Platelet-rich Fibrin in Extraction Socket vs Graftless Healing
The present study will be performed to:
evaluate alveolar bone healing using dentin autograft mixed with platelet-rich plasma in extraction socket vs graftless healing.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
When teeth are extracted, a certain amount of bone loss or resorption occurs, usually about 30-60%.
This loss is typically three-dimensional in nature, with width loss or horizontal deficiency developing to a greater extent than other types of deficiencies.
An alveolar defect can be classified as the loss of labial or buccal cortical or medullary bone.
In some cases, both exist.
Although all alveolar defects present challenges when planning a dental implant procedure, if the defect is in the buccal cortex or cortical plate after tooth extraction, this can create significant difficulties in the reconstruction of a dental implant.
Bone loss or bone augmentation techniques have been developed to counteract alveolar defects, such as guided bone regeneration, onlay block bone grafting, ridge/split bone grafting, and alveolar distraction osteogenesis.
These procedures can help improve an alveolar defect and prepare the alveolar ridge for a successful dental implant.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt, 11553
- Faculty of Dentistry, Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 1. Patients with hopeless non molar teeth that need extraction. 2. Age above 18 years. 3. Generally good state of health. 4. Agreement to participate in the study and also have to be able to attend postoperative clinical and radiological follow-up 6. Acquisition of informed consent.
Exclusion Criteria:
1- Patients refuse to be enrolled in this study
2- Patients with uncontrolled systemic disease.
3- Previously diagnosed hematological and neurological conditions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Graftless Healing (Control)
Participants undergo atraumatic extraction of a hopeless non-molar tooth.
The extraction socket is left to heal spontaneously without placement of any grafting material.
The socket is sutured with 3-0 Vicryl to allow primary wound closure.
Clinical, radiographic, and histomorphometric evaluations are performed according to the study follow-up schedule.
|
|
|
Experimental: Autogenous Dentin Graft Mixed with Platelet-Rich Plasma (PRP)
Participants undergo atraumatic extraction of a hopeless non-molar tooth followed by immediate socket preservation using an autogenous dentin graft prepared from the extracted tooth.
The dentin particles are processed using the Smart Dentin Grinder system, disinfected, rinsed with phosphate-buffered saline, and mixed with autologous platelet-rich plasma (PRP) to produce a sticky dentin graft.
The graft is placed into the extraction socket, and the surgical site is sutured with 3-0 Vicryl.
Clinical, radiographic, and histomorphometric outcomes are evaluated throughout the follow-up period.
|
DENTION IS HARVESTED FROM NON RESTORABLE TOOTH TO BE GROUND AND MIXED WITH PRF TO BE APPLIED IN EXTRACTION SOCKETS < 1ST GROUP> PRF IS WITHDROWN FROM BLOOD AND CENTRIFUGED TO FORM A GRAFT TO BE APPLIED IN EXTRACTION SOCKETS <2ND GROUP> EXTRACTION SOCKETS ARE LEFT TO HEAL SPONTANUOUSLY
|
|
Experimental: Platelets rich fibrin applied in the socket
PRF from patient own blood is applied to the socket
|
DENTION IS HARVESTED FROM NON RESTORABLE TOOTH TO BE GROUND AND MIXED WITH PRF TO BE APPLIED IN EXTRACTION SOCKETS < 1ST GROUP> PRF IS WITHDROWN FROM BLOOD AND CENTRIFUGED TO FORM A GRAFT TO BE APPLIED IN EXTRACTION SOCKETS <2ND GROUP> EXTRACTION SOCKETS ARE LEFT TO HEAL SPONTANUOUSLY
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Histomorphometric bone formation (%)
Time Frame: 3-6 months
|
a trephine bur is used to extract a sample from healed bone to be stained with H&E and analyzed under microscope
|
3-6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone density (radiographic) Healing index
Time Frame: 3-6 months
|
type of bone is measerd on cbct scan after three months from healing of bone
|
3-6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Actual)
January 13, 2026
Study Completion (Actual)
July 1, 2026
Study Registration Dates
First Submitted
August 27, 2026
First Submitted That Met QC Criteria
August 27, 2026
First Posted (Actual)
September 1, 2026
Study Record Updates
Last Update Posted (Actual)
September 1, 2026
Last Update Submitted That Met QC Criteria
August 27, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- Dentine autograft vs PRF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data (IPD) will not be shared because the study was not designed with participant-level data sharing.
The collected data contain confidential information, and participants did not provide consent for public sharing of de-identified individual-level data.
Only aggregate study results will be published.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.